During the past decade, PERSONAL - Oncologia de Precisão e Personalizada conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PERSONAL - Oncologia de Precisão e Personalizada" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Carcinoma, Non-small-Cell Lung" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "PERSONAL - Oncologia de Precisão e Personalizada" in a lesser frequency.

Most popular intervention types in "PERSONAL - Oncologia de Precisão e Personalizada" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (2 trials), "Niraparib" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "AMG 510" (1 trials). Other intervention names were less common.

The vast majority of trials in "PERSONAL - Oncologia de Precisão e Personalizada" are 5 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "PERSONAL - Oncologia de Precisão e Personalizada". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in PERSONAL - Oncologia de Precisão e Personalizada, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PERSONAL - Oncologia de Precisão e Personalizada, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".